(en) Abel S, Russell D, Whitlock LA, Ridgway CE, Nedderman AN, Walker DK, « Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects », British Journal of Clinical Pharmacology, vol. 65, no Suppl 1, , p. 60–7 (PMID18333867, PMCID2311408, DOI10.1111/j.1365-2125.2008.03137.x)
(en) Abel S, Russell D, Whitlock LA, Ridgway CE, Nedderman AN, Walker DK, « Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects », British Journal of Clinical Pharmacology, vol. 65, no Suppl 1, , p. 60–7 (PMID18333867, PMCID2311408, DOI10.1111/j.1365-2125.2008.03137.x)
(en) Abel S, Back DJ, Vourvahis M, « Maraviroc: pharmacokinetics and drug interactions », Antiviral Therapy, vol. 14, no 5, , p. 607–18 (PMID19704163)
Deeks SG, Tracy R, Douek DC.. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39:633-45; PMID24138880; https://dx.doi.org/10.1016/j.immuni.2013.10.001 [PMC free article] [PubMed] [CrossRef]
Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-90; PMID21252259; https://dx.doi.org/10.1093/infdis/jiq118 [PMC free article][PubMed] [CrossRef]
Tenorio AR, Zheng Y, Bosch RJ, Krishnan S, Rodriguez B, Hunt PW, Plants J, Seth A, Wilson CC, Deeks SG, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis 2014; 210:1248-59; PMID24795473; https://dx.doi.org/10.1093/infdis/jiu254 [PMC free article] [PubMed] [CrossRef]
Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis 2014; 210:1228-38; PMID24755434; https://dx.doi.org/10.1093/infdis/jiu238 [PMC free article] [PubMed] [CrossRef]
Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, et al. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog 2016; 12:e1005540; PMID27015639; https://dx.doi.org/10.1371/journal.ppat.1005540 [PMC free article] [PubMed] [CrossRef]
